The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-Restenosis Stents Market Research Report 2025
Synopsis
The global Anti-Restenosis Stents market was valued at US$ 1562.2 million in 2023 and is anticipated to reach US$ 2164.9 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
Drug-Eluting Stents (DES): The dominance of drug-eluting stents continues to grow. These stents are coated with medications that help inhibit cell proliferation and reduce the risk of restenosis.
Biodegradable Stents: Biodegradable stents are designed to dissolve over time, reducing the risk of long-term complications associated with permanent stents. These stents are gaining traction, especially for specific patient populations.
Bioresorbable Scaffolds: Bioresorbable scaffolds provide temporary support to blood vessels, slowly breaking down over time as the vessel heals. They are designed to address restenosis while allowing the vessel to return to its natural state.
This report aims to provide a comprehensive presentation of the global market for Anti-Restenosis Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Restenosis Stents.
Report Scope
The Anti-Restenosis Stents market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Restenosis Stents market comprehensively. Regional market sizes, concerning products by Materials, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Restenosis Stents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Materials, by Application, and by regions.
Market Segmentation
By Company
Sono-Tek Corporation
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Sahajanand Medical Technologies
J&J/Cordis
Segment by Materials
Cobalt-Chromium Alloy Stents
Magnesium Alloy Stents
Nitinol Stents
Other Materials
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Materials, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Restenosis Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Restenosis Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Materials, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Anti-Restenosis Stents market was valued at US$ 1562.2 million in 2023 and is anticipated to reach US$ 2164.9 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
Drug-Eluting Stents (DES): The dominance of drug-eluting stents continues to grow. These stents are coated with medications that help inhibit cell proliferation and reduce the risk of restenosis.
Biodegradable Stents: Biodegradable stents are designed to dissolve over time, reducing the risk of long-term complications associated with permanent stents. These stents are gaining traction, especially for specific patient populations.
Bioresorbable Scaffolds: Bioresorbable scaffolds provide temporary support to blood vessels, slowly breaking down over time as the vessel heals. They are designed to address restenosis while allowing the vessel to return to its natural state.
This report aims to provide a comprehensive presentation of the global market for Anti-Restenosis Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Restenosis Stents.
Report Scope
The Anti-Restenosis Stents market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Restenosis Stents market comprehensively. Regional market sizes, concerning products by Materials, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Restenosis Stents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Materials, by Application, and by regions.
Market Segmentation
By Company
Sono-Tek Corporation
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Sahajanand Medical Technologies
J&J/Cordis
Segment by Materials
Cobalt-Chromium Alloy Stents
Magnesium Alloy Stents
Nitinol Stents
Other Materials
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Materials, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Restenosis Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Restenosis Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Materials, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Anti-Restenosis Stents Market Overview
1.1 Product Overview and Scope of Anti-Restenosis Stents
1.2 Anti-Restenosis Stents Segment by Materials
1.2.1 Global Anti-Restenosis Stents Market Value Comparison by Materials (2024-2030)
1.2.2 Cobalt-Chromium Alloy Stents
1.2.3 Magnesium Alloy Stents
1.2.4 Nitinol Stents
1.2.5 Other Materials
1.3 Anti-Restenosis Stents Segment by Application
1.3.1 Global Anti-Restenosis Stents Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Anti-Restenosis Stents Market Size Estimates and Forecasts
1.4.1 Global Anti-Restenosis Stents Revenue 2019-2030
1.4.2 Global Anti-Restenosis Stents Sales 2019-2030
1.4.3 Global Anti-Restenosis Stents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-Restenosis Stents Market Competition by Manufacturers
2.1 Global Anti-Restenosis Stents Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-Restenosis Stents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-Restenosis Stents Average Price by Manufacturers (2019-2024)
2.4 Global Anti-Restenosis Stents Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Restenosis Stents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Restenosis Stents, Product Type & Application
2.7 Anti-Restenosis Stents Market Competitive Situation and Trends
2.7.1 Anti-Restenosis Stents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Restenosis Stents Players Market Share by Revenue
2.7.3 Global Anti-Restenosis Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Restenosis Stents Retrospective Market Scenario by Region
3.1 Global Anti-Restenosis Stents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-Restenosis Stents Global Anti-Restenosis Stents Sales by Region: 2019-2030
3.2.1 Global Anti-Restenosis Stents Sales by Region: 2019-2024
3.2.2 Global Anti-Restenosis Stents Sales by Region: 2025-2030
3.3 Global Anti-Restenosis Stents Global Anti-Restenosis Stents Revenue by Region: 2019-2030
3.3.1 Global Anti-Restenosis Stents Revenue by Region: 2019-2024
3.3.2 Global Anti-Restenosis Stents Revenue by Region: 2025-2030
3.4 North America Anti-Restenosis Stents Market Facts & Figures by Country
3.4.1 North America Anti-Restenosis Stents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-Restenosis Stents Sales by Country (2019-2030)
3.4.3 North America Anti-Restenosis Stents Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Restenosis Stents Market Facts & Figures by Country
3.5.1 Europe Anti-Restenosis Stents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-Restenosis Stents Sales by Country (2019-2030)
3.5.3 Europe Anti-Restenosis Stents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Restenosis Stents Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Restenosis Stents Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-Restenosis Stents Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-Restenosis Stents Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Anti-Restenosis Stents Market Facts & Figures by Country
3.7.1 Latin America Anti-Restenosis Stents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-Restenosis Stents Sales by Country (2019-2030)
3.7.3 Latin America Anti-Restenosis Stents Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-Restenosis Stents Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Restenosis Stents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-Restenosis Stents Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-Restenosis Stents Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Materials
4.1 Global Anti-Restenosis Stents Sales by Materials (2019-2030)
4.1.1 Global Anti-Restenosis Stents Sales by Materials (2019-2024)
4.1.2 Global Anti-Restenosis Stents Sales by Materials (2025-2030)
4.1.3 Global Anti-Restenosis Stents Sales Market Share by Materials (2019-2030)
4.2 Global Anti-Restenosis Stents Revenue by Materials (2019-2030)
4.2.1 Global Anti-Restenosis Stents Revenue by Materials (2019-2024)
4.2.2 Global Anti-Restenosis Stents Revenue by Materials (2025-2030)
4.2.3 Global Anti-Restenosis Stents Revenue Market Share by Materials (2019-2030)
4.3 Global Anti-Restenosis Stents Price by Materials (2019-2030)
5 Segment by Application
5.1 Global Anti-Restenosis Stents Sales by Application (2019-2030)
5.1.1 Global Anti-Restenosis Stents Sales by Application (2019-2024)
5.1.2 Global Anti-Restenosis Stents Sales by Application (2025-2030)
5.1.3 Global Anti-Restenosis Stents Sales Market Share by Application (2019-2030)
5.2 Global Anti-Restenosis Stents Revenue by Application (2019-2030)
5.2.1 Global Anti-Restenosis Stents Revenue by Application (2019-2024)
5.2.2 Global Anti-Restenosis Stents Revenue by Application (2025-2030)
5.2.3 Global Anti-Restenosis Stents Revenue Market Share by Application (2019-2030)
5.3 Global Anti-Restenosis Stents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sono-Tek Corporation
6.1.1 Sono-Tek Corporation Corporation Information
6.1.2 Sono-Tek Corporation Description and Business Overview
6.1.3 Sono-Tek Corporation Anti-Restenosis Stents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sono-Tek Corporation Anti-Restenosis Stents Product Portfolio
6.1.5 Sono-Tek Corporation Recent Developments/Updates
6.2 Abbott Vascular
6.2.1 Abbott Vascular Corporation Information
6.2.2 Abbott Vascular Description and Business Overview
6.2.3 Abbott Vascular Anti-Restenosis Stents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Vascular Anti-Restenosis Stents Product Portfolio
6.2.5 Abbott Vascular Recent Developments/Updates
6.3 Advantec Vascular
6.3.1 Advantec Vascular Corporation Information
6.3.2 Advantec Vascular Description and Business Overview
6.3.3 Advantec Vascular Anti-Restenosis Stents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Advantec Vascular Anti-Restenosis Stents Product Portfolio
6.3.5 Advantec Vascular Recent Developments/Updates
6.4 B.Braun Melsengen AG
6.4.1 B.Braun Melsengen AG Corporation Information
6.4.2 B.Braun Melsengen AG Description and Business Overview
6.4.3 B.Braun Melsengen AG Anti-Restenosis Stents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 B.Braun Melsengen AG Anti-Restenosis Stents Product Portfolio
6.4.5 B.Braun Melsengen AG Recent Developments/Updates
6.5 Biosensors
6.5.1 Biosensors Corporation Information
6.5.2 Biosensors Description and Business Overview
6.5.3 Biosensors Anti-Restenosis Stents Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biosensors Anti-Restenosis Stents Product Portfolio
6.5.5 Biosensors Recent Developments/Updates
6.6 Biotronik
6.6.1 Biotronik Corporation Information
6.6.2 Biotronik Description and Business Overview
6.6.3 Biotronik Anti-Restenosis Stents Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biotronik Anti-Restenosis Stents Product Portfolio
6.6.5 Biotronik Recent Developments/Updates
6.7 Blue Medical
6.6.1 Blue Medical Corporation Information
6.6.2 Blue Medical Description and Business Overview
6.6.3 Blue Medical Anti-Restenosis Stents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Blue Medical Anti-Restenosis Stents Product Portfolio
6.7.5 Blue Medical Recent Developments/Updates
6.8 Boston Scientific
6.8.1 Boston Scientific Corporation Information
6.8.2 Boston Scientific Description and Business Overview
6.8.3 Boston Scientific Anti-Restenosis Stents Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Boston Scientific Anti-Restenosis Stents Product Portfolio
6.8.5 Boston Scientific Recent Developments/Updates
6.9 DISA Vascular
6.9.1 DISA Vascular Corporation Information
6.9.2 DISA Vascular Description and Business Overview
6.9.3 DISA Vascular Anti-Restenosis Stents Sales, Revenue and Gross Margin (2019-2024)
6.9.4 DISA Vascular Anti-Restenosis Stents Product Portfolio
6.9.5 DISA Vascular Recent Developments/Updates
6.10 Essen
6.10.1 Essen Corporation Information
6.10.2 Essen Description and Business Overview
6.10.3 Essen Anti-Restenosis Stents Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Essen Anti-Restenosis Stents Product Portfolio
6.10.5 Essen Recent Developments/Updates
6.11 Medtronic Vascular
6.11.1 Medtronic Vascular Corporation Information
6.11.2 Medtronic Vascular Anti-Restenosis Stents Description and Business Overview
6.11.3 Medtronic Vascular Anti-Restenosis Stents Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Medtronic Vascular Anti-Restenosis Stents Product Portfolio
6.11.5 Medtronic Vascular Recent Developments/Updates
6.12 MicroPort Medical
6.12.1 MicroPort Medical Corporation Information
6.12.2 MicroPort Medical Anti-Restenosis Stents Description and Business Overview
6.12.3 MicroPort Medical Anti-Restenosis Stents Sales, Revenue and Gross Margin (2019-2024)
6.12.4 MicroPort Medical Anti-Restenosis Stents Product Portfolio
6.12.5 MicroPort Medical Recent Developments/Updates
6.13 MIV Therapeutics
6.13.1 MIV Therapeutics Corporation Information
6.13.2 MIV Therapeutics Anti-Restenosis Stents Description and Business Overview
6.13.3 MIV Therapeutics Anti-Restenosis Stents Sales, Revenue and Gross Margin (2019-2024)
6.13.4 MIV Therapeutics Anti-Restenosis Stents Product Portfolio
6.13.5 MIV Therapeutics Recent Developments/Updates
6.14 Orbusneich
6.14.1 Orbusneich Corporation Information
6.14.2 Orbusneich Anti-Restenosis Stents Description and Business Overview
6.14.3 Orbusneich Anti-Restenosis Stents Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Orbusneich Anti-Restenosis Stents Product Portfolio
6.14.5 Orbusneich Recent Developments/Updates
6.15 Sahajanand Medical Technologies
6.15.1 Sahajanand Medical Technologies Corporation Information
6.15.2 Sahajanand Medical Technologies Anti-Restenosis Stents Description and Business Overview
6.15.3 Sahajanand Medical Technologies Anti-Restenosis Stents Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sahajanand Medical Technologies Anti-Restenosis Stents Product Portfolio
6.15.5 Sahajanand Medical Technologies Recent Developments/Updates
6.16 J&J/Cordis
6.16.1 J&J/Cordis Corporation Information
6.16.2 J&J/Cordis Anti-Restenosis Stents Description and Business Overview
6.16.3 J&J/Cordis Anti-Restenosis Stents Sales, Revenue and Gross Margin (2019-2024)
6.16.4 J&J/Cordis Anti-Restenosis Stents Product Portfolio
6.16.5 J&J/Cordis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Restenosis Stents Industry Chain Analysis
7.2 Anti-Restenosis Stents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Restenosis Stents Production Mode & Process
7.4 Anti-Restenosis Stents Sales and Marketing
7.4.1 Anti-Restenosis Stents Sales Channels
7.4.2 Anti-Restenosis Stents Distributors
7.5 Anti-Restenosis Stents Customers
8 Anti-Restenosis Stents Market Dynamics
8.1 Anti-Restenosis Stents Industry Trends
8.2 Anti-Restenosis Stents Market Drivers
8.3 Anti-Restenosis Stents Market Challenges
8.4 Anti-Restenosis Stents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
